For T1D patients, exogenous insulin delivered via injections or pumps can provide a solution; however, because these therapies cannot fully mimic the inherently complex function of the endocrine pancreas, they are ultimately inadequate, leading to chronic and degenerative complications [3]. The gene discussed is INS; the disease is type 1 diabetes mellitus.